Phencyclidine (PCP) Saliva Rapid Test

Phencyclidine, commonly known as PCP, is a dissociative drug associated with hallucinogenic and mind-altering effects. In drug screening, PCP is important because it may be linked with unsafe behavior, impaired coordination, altered perception, confusion, and serious safety concerns. The Phencyclidine PCP Saliva Rapid Test helps professional users screen oral-fluid samples quickly and decide whether confirmatory testing is needed.

• The PCP saliva rapid test is useful where fast oral-fluid screening is required. Saliva testing can support observed specimen collection and reduce the need for private urine collection.
• The LARKSOIS Pharma PCP Saliva Rapid Test may be used in workplace and pre-employment screening support, rehabilitation monitoring, clinical toxicology screening, forensic testing, roadside screening where legally permitted, and international diagnostic distribution.
• This PCP oral-fluid test is designed for professional screening use and should be interpreted according to the product insert and applicable local regulations.

The Phencyclidine (PCP) Saliva Rapid Test by LARKSOIS Pharma may be used in professional diagnostic and institutional screening environments.

Applications

• Workplace and pre-employment screening support
• Rehabilitation and de-addiction monitoring
• Clinical toxicology screening
• Forensic and compliance screening
• Roadside or recent-exposure screening programs where legally permitted
• Laboratories and diagnostic distributors
• International drug of abuse testing markets
• Professional oral-fluid screening workflows

• The Phencyclidine PCP Saliva Rapid Test generally works through a rapid immunoassay format. A saliva sample is collected using the approved oral-fluid collection method, and the test result is read within the stated time window.
• The 20 ng/mL cut-off means the test is designed to screen for PCP at or above the stated threshold.
• A negative result means PCP was not detected above the cut-off at the time of testing. A non-negative result means PCP may be present and should be confirmed when required.

The Phencyclidine (PCP) Saliva Rapid Test uses a rapid oral-fluid screening method for qualitative detection of PCP. It is designed to provide a preliminary screening result at the stated 20 ng/mL cut-off.

Benefits

• Oral-fluid based PCP screening
• 20 ng/mL cut-off for professional screening needs
• Fast qualitative drug of abuse screening
• Non-invasive saliva specimen collection
• Suitable for observed collection settings
• Useful for workplace, rehabilitation, clinical, forensic, and roadside screening
• Easy-to-read rapid test format
• Designed for international diagnostic supply markets

The Phencyclidine (PCP) Saliva Rapid Test is designed for saliva or oral-fluid specimens. Saliva testing is practical, non-invasive, and useful for professional screening programs where observed collection and rapid results are important.

Guidance

• Use saliva or oral-fluid specimens only
• Collect saliva using the approved oral-fluid procedure
• Avoid specimen contamination
• Follow the package insert carefully
• Read results only within the stated time window
• Do not reuse the test device
• Confirm important or disputed results through laboratory testing

Note

A rapid screening result should be considered preliminary unless confirmed by a validated laboratory method where required.

The Phencyclidine (PCP) Saliva Rapid Test by LARKSOIS Pharma has a stated cut-off of 20 ng/mL. This means the test is designed to screen oral-fluid specimens for PCP at or above the validated threshold. LARKSOIS Pharma should mention the exact performance details according to the final product insert, technical file, and regulatory documentation.

The PCP saliva test is a screening product, not a final diagnostic result. A negative result does not always mean no PCP is present; the level may be below the test cut-off or outside the detection window. A non-negative result does not prove impairment, addiction, misuse, or exact timing of drug use.

Instructions

• A positive result is preliminary only
• A negative result does not always rule out exposure
• Drug levels may be below the cut-off concentration
• Specimen quality may affect the result
• Oral-fluid collection technique may affect performance
• Testing method differences may affect interpretation
• Confirmatory testing is recommended for important results

Instructions

• Fast oral-fluid screening for PCP
• 20 ng/mL cut-off for professional screening requirements
• Non-invasive saliva specimen collection
• Suitable for observed collection settings
• Useful for drug of abuse screening programs
• Supports workplace, clinical, rehabilitation, roadside, and forensic testing
• Easy-to-read rapid test format
• Designed for international diagnostic supply markets

Note

The Phencyclidine PCP Saliva Rapid Test by LARKSOIS Pharma provides a practical screening option for professional users who need speed, convenience, and reliable preliminary testing.

Steps

• Bring the test device and saliva collection materials to the recommended testing condition
• Open the sealed pouch only when ready to test
• Collect saliva according to the approved oral-fluid collection method
• Apply or process the saliva specimen according to the test instructions
• Wait for the test reaction to complete within the instructed time
• Read the result within the approved interpretation window
• Dispose of used materials according to laboratory safety rules

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the Phencyclidine (PCP) Saliva Rapid Test.

Positive

A positive or non-negative result suggests that PCP may be present in the saliva specimen at or above the stated cut-off. Positive results are preliminary and should be confirmed using a recognized laboratory method where required.

Negative

A negative result suggests that PCP was not detected or was below the cut-off at the time of testing. A negative result does not always rule out exposure if sample quality, collection timing, or the detection window affects the result.

Invalid

If the valid control indicator does not appear, the test is invalid. The test should be repeated with a new device and properly collected saliva specimen according to the product insert.

Instructions

• Store according to the product label and package insert
• Keep the test device sealed until use
• Protect from moisture and direct sunlight
• Avoid using expired or damaged kits
• Use only approved oral-fluid collection materials
• Read results only within the stated time window
• Do not reuse the test device

Instructions

• For professional screening use only
• Use saliva or oral-fluid specimen only as directed
• Do not reuse the test device
• Follow the product insert carefully
• Avoid specimen contamination
• Handle all specimens with standard safety precautions
• Do not interpret results after the recommended reading time
• Confirm presumptive positive results with laboratory testing
• Follow applicable drug testing laws and reporting requirements

LARKSOIS Pharma provides international-quality pharmaceutical and diagnostic products for healthcare, screening, and global supply markets. The Phencyclidine PCP Saliva Rapid Test is developed for professional use by distributors, laboratories, hospitals, rehabilitation centers, workplace testing companies, roadside screening programs, and toxicology departments.

Advantages

• International diagnostic product focus
• Reliable rapid testing solutions
• Suitable for laboratories and healthcare suppliers
• Distributor-friendly product format
• Supports drug of abuse screening programs
• Designed for practical oral-fluid screening workflows
• Quality-focused standards under LARKSOIS Pharma